Citadel Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.95M | Sell |
110,000
-26,200
| -19% | -$2.4M | ﹤0.01% | 3264 |
|
|
2025
Q4 | $12.2M | Buy |
136,200
+98,200
| +258% | +$9.31M | ﹤0.01% | 2987 |
|
|
2025
Q3 | $3.74M | Buy |
38,000
+3,300
| +10% | +$327K | ﹤0.01% | 4894 |
|
|
2025
Q2 | $3.16M | Sell |
34,700
-6,300
| -15% | -$609K | ﹤0.01% | 4885 |
|
|
2025
Q1 | $4.64M | Sell |
41,000
-100,000
| -71% | -$10.7M | ﹤0.01% | 3995 |
|
|
2024
Q4 | $14.9M | Sell |
141,000
-1,600
| -1% | -$172K | ﹤0.01% | 2494 |
|
|
2024
Q3 | $15.4M | Buy |
142,600
+75,800
| +113% | +$8.27M | ﹤0.01% | 2348 |
|
|
2024
Q2 | $7.25M | Sell |
66,800
-116,300
| -64% | -$13.7M | ﹤0.01% | 3222 |
|
|
2024
Q1 | $24.2M | Sell |
183,100
-25,700
| -12% | -$3.21M | ﹤0.01% | 1880 |
|
|
2023
Q4 | $25.4M | Sell |
208,800
-199,700
| -49% | -$22.3M | 0.01% | 1778 |
|
|
2023
Q3 | $45.8M | Buy |
408,500
+331,300
| +429% | +$42.1M | 0.01% | 1135 |
|
|
2023
Q2 | $11.2M | Buy |
77,200
+58,100
| +304% | +$7.9M | ﹤0.01% | 2526 |
|
|
2023
Q1 | $2.47M | Sell |
19,100
-25,500
| -57% | -$3.2M | ﹤0.01% | 4986 |
|
|
2022
Q4 | $5.69M | Sell |
44,600
-400
| -0.9% | -$46.4K | ﹤0.01% | 3641 |
|
|
2022
Q3 | $4.71M | Buy |
45,000
+19,000
| +73% | +$2.09M | ﹤0.01% | 3981 |
|
|
2022
Q2 | $2.73M | Sell |
26,000
-179,500
| -87% | -$21.3M | ﹤0.01% | 4934 |
|
|
2022
Q1 | $26.3M | Buy |
205,500
+111,667
| +119% | +$13.5M | 0.01% | 1690 |
|
|
2021
Q4 | $11.6M | Sell |
93,833
-114,948
| -55% | -$15M | ﹤0.01% | 2819 |
|
|
2021
Q3 | $29.7M | Buy |
208,781
+131,531
| +170% | +$19.3M | 0.01% | 1579 |
|
|
2021
Q2 | $12.1M | Buy |
77,250
+25,029
| +48% | +$4.05M | ﹤0.01% | 2798 |
|
|
2021
Q1 | $8.12M | Buy |
52,221
+5,665
| +12% | +$878K | ﹤0.01% | 3303 |
|
|
2020
Q4 | $6.96M | Sell |
46,556
-13,596
| -23% | -$1.92M | ﹤0.01% | 3127 |
|
|
2020
Q3 | $7.95M | Sell |
60,152
-75,190
| -56% | -$9.82M | ﹤0.01% | 2569 |
|
|
2020
Q2 | $15.7M | Buy |
135,342
+56,341
| +71% | +$6.49M | 0.01% | 1724 |
|
|
2020
Q1 | $7.75M | Buy |
79,001
+32,239
| +69% | +$4.23M | ﹤0.01% | 2158 |
|
|
2019
Q4 | $6.79M | Sell |
46,762
-56,547
| -55% | -$7.81M | ﹤0.01% | 2684 |
|
|
2019
Q3 | $13.8M | Buy |
103,309
+44,908
| +77% | +$5.8M | 0.01% | 1861 |
|
|
2019
Q2 | $6.68M | Buy |
58,401
+36,050
| +161% | +$4.22M | ﹤0.01% | 2692 |
|
|
2019
Q1 | $2.77M | Sell |
22,351
-2,060
| -8% | -$234K | ﹤0.01% | 3895 |
|
|
2018
Q4 | $2.46M | Sell |
24,411
-8,549
| -26% | -$961K | ﹤0.01% | 3828 |
|
|
2018
Q3 | $4.21M | Buy |
32,960
+15,244
| +86% | +$1.81M | ﹤0.01% | 3219 |
|
|
2018
Q2 | $1.92M | Sell |
17,716
-10,609
| -37% | -$1.15M | ﹤0.01% | 4179 |
|
|
2018
Q1 | $3M | Sell |
28,325
-25,647
| -48% | -$2.98M | ﹤0.01% | 3142 |
|
|
2017
Q4 | $6.32M | Buy |
53,972
+15,038
| +39% | +$1.7M | ﹤0.01% | 2193 |
|
|
2017
Q3 | $4.43M | Buy |
38,934
+22,145
| +132% | +$2.56M | ﹤0.01% | 2436 |
|
|
2017
Q2 | $2.09M | Sell |
16,789
-10,197
| -38% | -$1.21M | ﹤0.01% | 3113 |
|
|
2017
Q1 | $3.2M | Sell |
26,986
-43,363
| -62% | -$4.91M | ﹤0.01% | 2511 |
|
|
2016
Q4 | $7.05M | Buy |
70,349
+52,427
| +293% | +$5.62M | 0.01% | 1656 |
|
|
2016
Q3 | $2.26M | Sell |
17,922
-309
| -2% | -$38.2K | ﹤0.01% | 2825 |
|
|
2016
Q2 | $2.13M | Buy |
18,231
+7,416
| +69% | +$839K | ﹤0.01% | 2673 |
|
|
2016
Q1 | $1.12M | Sell |
10,815
-22,248
| -67% | -$2.15M | ﹤0.01% | 3351 |
|
|
2015
Q4 | $3.29M | Buy |
33,063
+10,403
| +46% | +$1.02M | ﹤0.01% | 2217 |
|
|
2015
Q3 | $2.07M | Sell |
22,660
-5,047
| -18% | -$506K | ﹤0.01% | 2900 |
|
|
2015
Q2 | $2.94M | Sell |
27,707
-8,240
| -23% | -$912K | ﹤0.01% | 2609 |
|
|
2015
Q1 | $4.1M | Sell |
35,947
-2,781
| -7% | -$317K | ﹤0.01% | 2245 |
|
|
2014
Q4 | $4.26M | Buy |
38,728
+20,703
| +115% | +$2.18M | ﹤0.01% | 2128 |
|
|
2014
Q3 | $1.76M | Sell |
18,025
-1,545
| -8% | -$152K | ﹤0.01% | 2995 |
|
|
2014
Q2 | $1.97M | Buy |
19,570
+4,429
| +29% | +$432K | ﹤0.01% | 2742 |
|
|
2014
Q1 | $1.39M | Sell |
15,141
-16,995
| -53% | -$1.57M | ﹤0.01% | 3011 |
|
|
2013
Q4 | $2.91M | Buy |
32,136
+3,090
| +11% | +$267K | ﹤0.01% | 2173 |
|
|
2013
Q3 | $2.32M | Buy |
29,046
+7,107
| +32% | +$559K | ﹤0.01% | 2277 |
|
|
2013
Q2 | $1.6M | Buy |
+21,939
| New | +$1.64M | ﹤0.01% | 2705 |
|
Other funds holding ZBH
VCM
VPM
Citadel Advisors's ZBH Position: Q1 2026 in Review
Citadel Advisors increased its Zimmer Biomet (ZBH) stake by 320% in Q1 2026, buying an estimated $96.4M and bringing the position to 1,378,665 shares worth $125M. The position accounts for 0.02% of the portfolio, ranked #676.
Citadel Advisors first reported a position in ZBH in Q2 2013 and has held it in 49 quarters since. The position peaked at $297M in Q4 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Citadel Advisors held 1,378,665 shares of Zimmer Biomet worth $125M as of Q1 2026.
- Citadel Advisors bought 1,050,289 Zimmer Biomet shares in Q1 2026, an estimated $96.4M.
- Zimmer Biomet made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #676 holding.
- Citadel Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Zimmer Biomet position peaked at $297M in Q4 2022.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.